These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3807103)

  • 21. Intravenous administration of sulpiride and heat sensation on the body surface.
    Kaneko Y; Yamamoto Y; Hosaka H
    Neuropsychobiology; 1983; 9(1):26-30. PubMed ID: 6888707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of dogmatil on postoperative depression].
    Jaques R
    Ann Chir; 1984 Dec; 38(9):693-7. PubMed ID: 6524853
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum dopamine-beta-hydroxylase activity in female manic-depressive patients.
    Rihmer Z; Bagdy G; Arató M
    Biol Psychiatry; 1984 Mar; 19(3):423-7. PubMed ID: 6722232
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapeutic effects and side effects in patients with major depression treated with sulpiride once a day.
    Tsukamoto T; Asakura M; Tsuneizumi T; Satoh Y; Shinozuka T; Hasegawa K
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 May; 18(3):615-8. PubMed ID: 8078993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensation seeking, mania, and monoamines.
    Zuckerman M
    Neuropsychobiology; 1985; 13(3):121-8. PubMed ID: 4047373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Plasma amitriptyline level and its therapeutic effectiveness in patients with affective disorders].
    Jakitowicz J
    Psychiatr Pol; 1991; 25(1):13-20. PubMed ID: 1780369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptic malignant syndrome due to sulpiride.
    Kashihara K; Ishida K
    J Neurol Neurosurg Psychiatry; 1988 Aug; 51(8):1109-10. PubMed ID: 3216219
    [No Abstract]   [Full Text] [Related]  

  • 28. Sulpiride-associated torsade de pointes in a woman with bipolar disorder.
    Teng PR; Shen TY; Lai TJ
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):246. PubMed ID: 22443253
    [No Abstract]   [Full Text] [Related]  

  • 29. Changes in platelet monoamine oxidase and plasma dopamine-beta-hydroxylase activities in lithium-treated bipolar patients.
    Sofuoğlu S; Doğan P; Köse K; Eşel E; Baştũrk M; Oğuz H; Gönül AS
    Psychiatry Res; 1995 Nov; 59(1-2):165-70. PubMed ID: 8771233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of lithium carbonate on serum dopamine beta-hydroxylase activity in endogenous depression].
    Grabowska M; Gumińska M; Broszkiewicz E
    Folia Med Cracov; 1980; 22(3-4):419-24. PubMed ID: 6793467
    [No Abstract]   [Full Text] [Related]  

  • 31. Some neuroendocrine parameters in bipolar and unipolar depression.
    Mendlewicz J; Linkowski P; Van Cauter E
    J Affect Disord; 1979 Mar; 1(1):25-32. PubMed ID: 162179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of clozapine on the excretion of 3-methoxy-4-hydroxy-phenylglycol, homovanillic acid and 5-hydroxy-indole acetic acid in urine and cerebrospinal fluid].
    Ackenheil M; Beckmann H; Hoffmann G; Markianos E; Nyström I; Raese J
    Arzneimittelforschung; 1974 Jul; 24(7):984-7. PubMed ID: 4408052
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma MHPG and age at onset in depressed patients.
    Karege F; Bovier P; Gaillard JM; Tissot R
    Psychiatry Res; 1989 Oct; 30(1):103-5. PubMed ID: 2594867
    [No Abstract]   [Full Text] [Related]  

  • 34. DBH, MHPG, and MAO in children with depressive, anxiety, and conduct disorders: relationship to diagnosis and symptom ratings.
    Pliszka SR; Rogeness GA; Medrano MA
    Psychiatry Res; 1988 Apr; 24(1):35-44. PubMed ID: 3393617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulpiride treatment of Cotard's syndrome in schizophrenia.
    Shiraishi H; Ito M; Hayashi H; Otani K
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):607-9. PubMed ID: 15093970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressant action of sulpiride. Results of a placebo-controlled double-blind trial.
    Rüther E; Degner D; Munzel U; Brunner E; Lenhard G; Biehl J; Vögtle-Junkert U
    Pharmacopsychiatry; 1999 Jul; 32(4):127-35. PubMed ID: 10505482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral effects of a new dopamine-beta-hydroxylase inhibitor (fusaric acid) in man.
    Goodwin FK; Sack RL
    J Psychiatr Res; 1974; 11():211-7. PubMed ID: 4618285
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum dopamine-beta-hydroxylase in manic-depressive psychosis.
    Ikeda Y; Ijima M; Nomura S
    Br J Psychiatry; 1982 Feb; 140():209-10. PubMed ID: 7074308
    [No Abstract]   [Full Text] [Related]  

  • 39. Amisulpride monotherapy may be a choice of maintenance treatment for patients with both bipolar I disorder and metabolic syndrome.
    Hong CC; Chen CK; Yeh TC; Chu CS; Chen TY
    Aust N Z J Psychiatry; 2015 Aug; 49(8):757-8. PubMed ID: 25788497
    [No Abstract]   [Full Text] [Related]  

  • 40. Failure to correlate urinary MHPG with clinical response to amitriptyline.
    Puzynski S; Rode A; Bidzinski A; Mrozek S; Zaluska M
    Acta Psychiatr Scand; 1984 Feb; 69(2):117-20. PubMed ID: 6702474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.